Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma

NCT00295503 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Mesothelioma

Interventions

DRUG: bevacizumab
DRUG: cisplatin
DRUG: pemetrexed

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]
[object Object]
[object Object]